Clinical Trial Update: Challenge Study of an ETEC Vaccine [Phase 2]

View source ↗

Summary

Phase 2 trial of an Enterotoxigenic Escherichia coli vaccine sponsored by the U.S. Army MRDC has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Enteritis
• Enterotoxigenic Escherichia Coli Infection

Drugs mentioned

• ETEC vaccine (Enterotoxigenic Escherichia coli vaccine)

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Enteritis; Escherichia Coli, Enterotoxigenic | Phase 2 | Status: COMPLETED